What is a T1 low‑risk polyp‑contained colorectal cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

T1 Low-Risk Polyp-Contained Colorectal Cancer: Definition and Criteria

A T1 low-risk polyp-contained colorectal cancer is a malignant polyp with submucosal invasion that meets ALL five histological criteria for favorable prognosis: submucosal invasion depth <1 mm, absence of lymphovascular invasion, well or moderately differentiated tumor histology, no tumor budding (or low-grade budding only), and negative resection margins ≥1 mm. 1

Core Definition

T1 colorectal cancer refers to a malignant polyp where cancer has invaded into the submucosa but has not penetrated through the muscularis propria—this is classified as pT1 in the TNM staging system. 1 The term "polyp-contained" indicates the cancer was discovered within a polypoid lesion and was amenable to endoscopic resection. 1

The Five Histological Criteria for Low-Risk Classification

For a T1 cancer to be considered "low-risk" or "favorable prognosis," it must satisfy ALL of the following criteria simultaneously: 1

  1. Submucosal invasion depth <1 mm (also termed sm1 or superficial submucosal invasion) 1

  2. Absence of lymphovascular invasion (no cancer cells within lymphatic or blood vessels) 1

  3. Well-differentiated or moderately differentiated tumor (low histologic grade, not poorly differentiated) 1

  4. No tumor budding (or only low-grade budding if present) 1

  5. Negative resection margins ≥1 mm (complete excision with adequate margin, no tumor within 1 mm of the resection edge) 1

Clinical Significance and Management Implications

When ALL five favorable criteria are met, the risk of lymph node metastasis drops to approximately 1-2%, making observation after complete endoscopic resection an acceptable curative strategy without additional surgery. 1, 2, 3

The overall lymph node metastasis risk in T1 colorectal cancer is approximately 15% across all cases. 1 However, this risk stratifies dramatically based on histological features. 2, 4, 5, 6

Low-Risk Management

  • Patients meeting all five favorable criteria should undergo observation only after complete endoscopic resection, with surveillance colonoscopy, CEA monitoring, abdominal ultrasound, and chest/abdominal CT scans. 1

  • Endoscopic follow-up should occur within 3-6 months if there is any uncertainty about margin status, and within 1 year if margins are definitively negative. 1

High-Risk Features Requiring Surgery

If ANY of the following unfavorable features are present, the patient is NOT low-risk and requires surgical resection with regional lymph node dissection: 1

  • Submucosal invasion ≥1 mm (or sm2-sm3 levels, particularly ≥1800 μm) 3, 6
  • Presence of lymphovascular invasion 1, 2, 6
  • Poorly differentiated or mucinous histology 1, 3
  • High-grade tumor budding 1, 4, 3
  • Positive or indeterminate resection margins (tumor within 1 mm of margin or at electrosurgical edge) 1
  • Specimen fragmentation preventing adequate pathological assessment 1

Critical Caveats and Common Pitfalls

The most common error is assuming that endoscopic resection alone is adequate without verifying ALL five favorable criteria. Missing even one unfavorable feature significantly increases lymph node metastasis risk from ~1-2% to 10-15% or higher. 1, 2, 4

Piecemeal resection of suspected malignant polyps should be avoided because specimen fragmentation prevents accurate assessment of invasion depth and margins, automatically placing the patient in the high-risk category requiring surgery. 1, 7

Even with favorable histology, the lymph node metastasis risk is not zero—it remains approximately 1.9% (95% CI: 0.5-4.8%). 2 Patients must be counseled that observation carries a small but real oncologic risk, and comprehensive staging with imaging and tumor markers is mandatory. 1

For sessile (non-pedunculated) polyps with cancer, the threshold for surgery is lower because adverse event rates (recurrence, mortality, hematogenous spread) are significantly higher compared to pedunculated polyps, particularly when margins are positive. 1

Depth of Invasion Measurement Systems

Different classification systems exist for measuring submucosal invasion depth: 4, 3, 5, 6

  • Absolute depth measurement: <1 mm is low-risk; ≥1 mm (particularly ≥1.8 mm or sm3) is high-risk 1, 3
  • Haggitt classification (for pedunculated polyps): Levels 1-3 are favorable; Level 4 is unfavorable 8
  • Kikuchi/sm classification: sm1 (<1000 μm) is favorable; sm2-sm3 (≥1000 μm) is unfavorable 3, 6

The most recent guidelines emphasize the <1 mm cutoff as the critical threshold for low-risk designation. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Current problems and perspectives of pathological risk factors for lymph node metastasis in T1 colorectal cancer: Systematic review.

Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, 2022

Research

The Natural History of pT1 Colorectal Cancer.

Frontiers in oncology, 2012

Guideline

Indications for Endoscopic Submucosal Dissection (ESD) in Sessile Polyps

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Recommendations for Management of Rectal Polyps

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.